Investing News NetworkFebruary 09, 2025Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain MetastasesDownload the PDF here.
Investing News Network29 August 2025 Appendix 4E and Preliminary Final Report Radiopharm Theranostics (RAD:AU) has announced Appendix 4E and Preliminary Final ReportDownload the PDF here. Keep Reading...
Investing News Network29 July 2025 Quarterly Activities/Appendix 4C Cash Flow Report Radiopharm Theranostics (RAD:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
Investing News Network27 July 2025 RAD receives IND approval from US FDA for Betabart (RV-01) Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)Download the PDF here. Keep Reading...
Investing News Network10 June 2025 RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases ImagingDownload the PDF here. Keep Reading...
Investing News Network03 June 2025 RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202Download the PDF here. Keep Reading...
Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services 18h
QIMC Highlights Technical Advisory Role on First Atlas Matane Natural Hydrogen Project Following Quebec Parliamentary Committee Appearance 05 June
precious metals investing Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services 18h
copper investing Nine Mile Metals Commences Trading on the OTCID Market, Expanding Access for U.S. Investors 19h
precious metals investing America's Antimony Gap Is Washington's Problem -- and NevGold Is Racing to Help Close It 05 June